Article
Reagents that block neuronal death from Huntington's disease also curb oxidative stress.
Neuroreport - 4 Jan 2012
Valencia Antonio, Sapp Ellen, Reeves Patrick B, Alexander Jonathan, Masso Nicholas, Li Xueyi, Kegel Kimberly B, DiFiglia Marian
Abstract excerpt
Patients with Huntington's disease suffer severe neuronal loss and signs of oxidative damage in the brain. Previously we found that primary neurons from embryonic cortex of mice bearing the Huntington's disease mutation (140 glutamines inserted into exon 1 of huntingtin) showed higher levels of reactive oxygen species before cell death. Here, we treated mutant neurons with known neuroprotective agents and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
